Free Trial

Stock Analyst Upgrades

View the latest stock upgrades, analyst upgrades, and updated analyst ratings in this real-time list of recent stock analyst recommendations. This page tracks every newly published upgrade, including changes to stock ratings, analyst recommendations, and price targets, helping you quickly review all the most recent upgrades and shifts in analyst coverage.

0 Results
CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Magnolia Oil & Gas Corp stock logo
MGY
Magnolia Oil & Gas
Upgraded by $22.98
+1.3%
$29.00Neutral ➝ Buy
MP Materials Corp. stock logo
MP
MP Materials
Upgraded by$36.42
-3.5%
$51.00Hold ➝ Buy
Morgan Stanley Direct Lending Fund stock logo
MSDL
Morgan Stanley Direct Lending Fund
Upgraded by$14.03
+0.5%
$15.50 ➝ $14.50Neutral ➝ Buy
Cloudflare, Inc. stock logo
NET
Cloudflare
Upgraded by $306.07
+4.2%
$300.00Sell ➝ Buy
Orion S.A. stock logo
OEC
Orion
Upgraded by$4.17
+2.8%
Underweight ➝ Neutral
PepGen, Inc. stock logo
PEPG
PepGen
Upgraded by $4.61
+92.9%
$2.50 ➝ $6.00Underperform ➝ Neutral
Southern Copper Corporation stock logo
SCCO
Southern Copper
Upgraded by$169.97
-3.4%
$180.00Sell ➝ Buy
SandRidge Energy, Inc. stock logo
SD
SandRidge Energy
Upgraded by $12.56
+2.6%
$14.00Hold ➝ Buy
Securitize Holdings stock logo
SECZ
Securitize
Upgraded by$8.55
+22.6%
$14.00Neutral ➝ Buy
Senseonics Holdings, Inc. Common Stock stock logo
SENS
Senseonics Holdings, Inc. Common Stock
Upgraded by$10.03
+2.3%
Underperform ➝ Market Perform
Your free book is about to disappear (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Upgraded by $16.42
-4.8%
$14.00 ➝ $18.00Sell ➝ Hold
WhiteHorse Finance, Inc. stock logo
WHF
WhiteHorse Finance
Upgraded by$8.05
-0.6%
$8.00 ➝ $9.00Neutral ➝ Buy
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
Upgraded by$1.80
+3.4%
$5.00 ➝ $6.00Neutral ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:20 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.